Study On R&D Strategy Of Pharmacy Of C Co. Ltd

Innovation is the best nutrition of company. The medicine industry is one of the industries with high content of science and technology, research and development of new drugs is the key to obtain the core competitiveness of the pharmaceutical enterprise channel for C company rely on generic drugs to achieve the initial development, but can not win the competition in the future market Therefore, it is necessary to enhance the management of new drug research and development to the level of strategic management, adjust development ideas, cultivate the ability of research and development, improve the level of drug development, provide a strong impetus for the innovation and development of enterprises.In this paper, the use of strategic management theory, product life cycle theory, analyzes the C company's internal conditions and external environment, comprehensive utilization of internal resources and external development opportunities, overcome internal weaknesses and external threats. Propose drug research strategy of C company. In the selection of new product strategy, focus on the two times development of the existing products of the dominant species, to carry out similar drug innovation of chemical drugs, imitate the patent expiration drug. In the development mode selection strategy, collaborative innovation, outsourcing contract and independent research and development mode respectively. In the strategy implementation steps, short period dominated by independent research and imitation; in the middle stage was dominated by joint research and improve dosage form; take long-term independent research and development, joint research and development, patent transaction strategy. Put forward to ensure the implementation of the strategy of the safeguard measures in four aspects: perfecting the financial security mechanism, improve the scientific incentive mechanism, perfect risk circumvention mechanism, improve the R & D marketing interaction mechanism.